Literature DB >> 31299321

Transient receptor potential vanilloid 4 is involved in the upregulation of connexin expression following pilocarpine-induced status epilepticus in mice.

Chen Men1, Zhouqing Wang2, Li Zhou2, Mengwen Qi2, Dong An2, Weixing Xu2, Yiyang Zhan3, Lei Chen4.   

Abstract

Epilepsy is characterized by spontaneous seizures. Changes in the expression of the connexins (Cxs) have been reported to be involved in epileptogenesis. It has previously been shown that the transient receptor potential vanilloid 4 (TRPV4) plays an important role in the modulation of neuronal excitability, and that application of a TRPV4 antagonist blocks hyperthermia-induced seizures. Accordingly, in the present study, we sought to explore whether TRPV4 is involved in the regulation of Cx expression following pilocarpine-induced status epilepticus (PISE) in mice. We observed that TRPV4 protein levels in hippocampi increased 3 h to 30 d following PISE, peaking 1-3 d after induction, and that pre-application of the TRPV4 antagonist HC-067047 increased the latency to develop SE induced by pilocarpine and reduced the success rate of PISE preparation. We demonstrated that Cx43 protein levels followed a time profile similar to that of TRPV4, and further showed that the increase in Cx43 protein levels on 3 d post-PISE was markedly attenuated by HC-067047. In contrast, the corresponding increase in Cx32 protein levels lagged substantially behind, and these levels were unaffected by HC-067047. Similarly, the TRPV4 agonist GSK1016790A increased the mRNA and protein levels of Cx43, but not those of Cx32. We thus conclude that the upregulation of Cx43 expression by TRPV4 may be involved in the pathophysiology of epilepsy.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Connexin; Hippocampus; Pilocarpine; Status epilepticus; Transient receptor potential vanilloid 4

Year:  2019        PMID: 31299321     DOI: 10.1016/j.brainresbull.2019.07.004

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  4 in total

1.  Blockage of TRPV4 Downregulates the Nuclear Factor-Kappa B Signaling Pathway to Inhibit Inflammatory Responses and Neuronal Death in Mice with Pilocarpine-Induced Status Epilepticus.

Authors:  Dong An; Xiuting Qi; Kunpeng Li; Weixing Xu; Yue Wang; Xi Chen; Sha Sha; Chunfeng Wu; Yimei Du; Lei Chen
Journal:  Cell Mol Neurobiol       Date:  2022-07-15       Impact factor: 4.231

2.  Anticonvulsant Effect of Carbenoxolone on Chronic Epileptic Rats and Its Mechanism Related to Connexin and High-Frequency Oscillations.

Authors:  Benke Liu; Xiao Ran; Yanjun Yi; Xinyu Zhang; Hengsheng Chen; Yue Hu
Journal:  Front Mol Neurosci       Date:  2022-05-09       Impact factor: 6.261

3.  TRPV4 Regulates Soman-Induced Status Epilepticus and Secondary Brain Injury via NMDA Receptor and NLRP3 Inflammasome.

Authors:  Shuai Wang; Huanhuan He; Jianhai Long; Xin Sui; Jun Yang; Guodong Lin; Qian Wang; Yongan Wang; Yuan Luo
Journal:  Neurosci Bull       Date:  2021-03-24       Impact factor: 5.271

Review 4.  Astrocytic Connexin43 Channels as Candidate Targets in Epilepsy Treatment.

Authors:  Laura Walrave; Mathieu Vinken; Luc Leybaert; Ilse Smolders
Journal:  Biomolecules       Date:  2020-11-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.